Advertisement
Heart, Lung and Circulation
Original Article| Volume 22, ISSUE 4, P284-290, April 2013

Impact of Traumatic Muscle Crush Injury as a Cause of Cardiomyocyte-specific Injury: An Experimental Study

  • Shuiping Liu
    Correspondence
    Corresponding author at: Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat-Sen University, 74 Zhongshan Road 2, Guangzhou 510080, PR China. Tel.: +86 2087331950; fax: +86 2087334353.
    Affiliations
    Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, PR China
    Search for articles by this author
  • Yangeng Yu
    Affiliations
    Forensic Science Center of Guangdong Provincial Public Security Department, Guangzhou, PR China
    Search for articles by this author
  • Bin Luo
    Affiliations
    Department of Forensic Pathology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, PR China
    Search for articles by this author
  • Xinbiao Liao
    Affiliations
    Forensic Science Center of Guangdong Provincial Public Security Department, Guangzhou, PR China
    Search for articles by this author
  • Zhi Tan
    Correspondence
    Corresponding author at: Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, 74 Zhongshan Road 2, Guangzhou 510080, PR China. Tel.: +86 2087330647; fax: +86 2087333232.
    Affiliations
    Department of Physiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, PR China
    Search for articles by this author
Published:December 17, 2012DOI:https://doi.org/10.1016/j.hlc.2012.11.008

      Background

      Muscle crush injury commonly occurs after earthquakes, collapse of buildings and sjambok beatings, and it often induces crush syndrome if not treated promptly. The general manifestation of crush syndrome is the presence of myoglobinuria with acute renal failure. However, whether cardiomyocyte injury is induced after muscle crush injury has not been investigated. The aim of this study was to observe the effects of muscle crush injury on cardiomyocyte injury and its relationship to the changes of ANP and ET-1 levels after muscle crush injury in rats.

      Methods

      Muscle crush injury was produced in Male Sprague-Dawley rats. Forty-eight rats were divided into six groups. The changes of electrocardiogram (ECG) were recorded. The serum levels of K+, Ca2+, urea, creatinine (CR), creatine kinase (CK), creatine kinase-myocardial band (CK-MB) and cardiac troponin I (cTnI) were detected by automated biochemical analysis and automated chemiluminescence assay, respectively. The myocardial and plasma levels of ANP and ET-1 were investigated by radioimmunoassay. Myocardial apoptosis and caspase-3 protein expression were quantitatively analysed by TUNEL-staining and Western blotting, respectively.

      Results

      After six hours of decompression, the serum levels of K+ and urea increased and ST-segment elevated and heart rates decreased pronouncedly over 48 h, CR increased and Ca2+ decreased considerably over 24 h. The serum levels of CK-MB and cTnI increased significantly from 6 h to 24 h and CK increased markedly from 0 h to 24 h after decompression and then decreased slowly. However, after 48 h of decompression, the serum levels of cTnI were still higher than those of the control group. Plasma levels of ANP and ET-1 increased and myocardial ANP and ET-1 decreased progressively over 48 h, and changed significantly from 6 h to 48 h after decompression. The number of TUNEL-positive myocytes and caspase-3 protein expression were higher from 6 h to 48 h after decompression. Moreover, the levels of K+, urea, CR, CK, CK-MB, cTnI and caspase-3 reached their highest values after 12 h of decompression. There were significant correlations between the plasma ANP elevation and the myocardial ANP decline, between the plasma ANP elevation and the plasma ET-1 increase, and between the plasma ET-1 increase and the myocardial ET-1 decline.

      Conclusions

      Cardiomyocyte injury was induced by muscle crush injury at the early stage of decompression but not at compression. The most dangerous period of cardiomyocyte injury was at the 12th hour of decompression. Cardiomyocyte injury may partly relate to the changes of ANP and ET-1.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Michaelson M.
        Crush injury and crush syndrome.
        World J Surg. 1992; 16: 899-903
        • Huerta-Alardín A.L.
        • Varon J.
        • Marik P.E.
        Bench-to-bedside review: rhabdomyolysis—an overview for clinicians.
        Crit Care. 2005; 9: 158-169
        • Gunal A.I.
        • Celiker H.
        • Dogukan A.
        • Ozalp G.
        • Kirciman E.
        • Simsekli H.
        • et al.
        Early and vigorous fluid resuscitation prevents acute renal failure in the crush victims of catastrophic earthquakes.
        J Am Soc Nephrol. 2004; 15: 1862-1867
        • Luck R.P.
        • Verbin S.
        Rhabdomyolysis: a review of clinical presentation, etiology, diagnosis, and management.
        Pediatr Emerg Care. 2008; 24: 262-268
        • Holt S.G.
        • Moore K.P.
        Pathogenesis and treatment of renal dysfunction in rhabdomyolysis.
        Intensive Care Med. 2001; 27: 803-811
        • Allister C.
        Cardiac arrest after crush injury.
        Br Med J (Clin Res Ed). 1983; 287: 531-532
        • Adachi K.
        • Kawata M.
        • Araki S.
        • Matsumoto A.
        • Mukai T.
        • Ikoma T.
        A case of crush syndrome with giant negative T waves and reversible left ventricular dysfunction.
        Jpn Circ J. 1996; 60: 809-814
        • Chin C.T.
        • Wang T.Y.
        • Li S.
        • Wiviott S.D.
        • deLemos J.A.
        • Kontos M.C.
        • et al.
        Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines.
        Clin Cardiol. 2012; 35: 424-429
        • Sagnella G.A.
        Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
        Clin Sci (Lond). 1998; 95: 519-529
        • Kasama S.
        • Furuya M.
        • Toyama T.
        • Ichikawa S.
        • Kurabayashi M.
        Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
        Eur Heart J. 2008; 29: 1485-1494
        • Miyauchi T.
        • Masaki T.
        Pathophysiology of endothelin in the cardiovascular system.
        Annu Rev Physiol. 1999; 61: 391-415
        • Wainwright C.L.
        • McCabe C.
        • Kane K.A.
        Endothelin and the ischaemic heart.
        Curr Vasc Pharmacol. 2005; 3: 333-341
        • Desai Shanti N.
        • Desai P.V.
        The study of Na+, K+-ATPase activity of rat brain during Crush syndrome.
        Neurochem Res. 2007; 32: 1843-1848
        • Wilson S.R.
        • Sabatine M.S.
        • Braunwald E.
        • Sloan S.
        • Murphy S.A.
        • Morrow D.A.
        Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial.
        Am Heart J. 2009; 158: 386-391
        • Lippi G.
        • Targher G.
        • Franchini M.
        • Plebani M.
        Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications.
        Clin Chem Lab Med. 2009; 47: 1183-1194
        • Gao F.
        • Gong B.
        • Christopher T.A.
        • Lopez B.L.
        • Karasawa A.
        • Ma X.L.
        Antiapoptotic effect of benidipine, a long-lasting vasodilating calcium antagonist, in ischaemic/reperfused myocardial cells.
        Br J Pharmacol. 2001; 132: 869-878
        • Odeh M.
        The role of reperfusion-induced injury in the pathogenesis of the crush syndrome.
        N Engl J Med. 1991; 324: 1417-1422
        • Vanholder R.
        • Sever M.S.
        • Erek E.
        • Lameire N.
        Rhabdomyolysis.
        J Am Soc Nephrol. 2000; 11: 1153-1161
        • Brown C.V.
        • Rhee P.
        • Chan L.
        • Evans K.
        • Demetriades D.
        • Velmahos G.C.
        Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?.
        J Trauma. 2004; 56: 1191-1196
        • McErlean E.S.
        • Deluca S.A.
        • van Lente F.
        • Peacock 4th, F.
        • Rao J.S.
        • Balog C.A.
        • et al.
        Comparison of troponin T versus creatine kinase-MB in suspected acute coronary syndromes.
        Am J Cardiol. 2000; 85: 421-426
        • Ilva T.
        • Lund J.
        • Porela P.
        • Mustonen H.
        • Voipio-Pulkki L.M.
        • Eriksson S.
        • et al.
        Early markers of myocardial injury: cTnI is enough.
        Clin Chim Acta. 2009; 400: 82-85
        • Lavoinne A.
        • Hue G.
        Serum cardiac troponins I and T in early posttraumatic rhabdomyolysis.
        Clin Chem. 1998; 44: 667-668
        • Collinson P.O.
        • Gaze D.C.
        Biomarkers of cardiovascular damage.
        Med Principles Pract. 2007; 16: 247-261
        • Kajstura J.
        • Cheng W.
        • Reiss K.
        • Clark W.A.
        • Sonnenblick E.H.
        • Krajewski S.
        • et al.
        Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats.
        Lab Invest. 1996; 74: 86-107
        • Maeno E.
        • Ishizaki Y.
        • Kanaseki T.
        • Hazama A.
        • Okada Y.
        Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis.
        Proc Natl Acad Sci USA. 2000; 97: 9487-9492
        • Omland T.
        • Hagve T.A.
        Natriuretic peptides: physiologic and analytic considerations.
        Heart Fail Clin. 2009; 5: 471-487
        • Sabrane K.
        • Kruse M.N.
        • Gazinski A.
        • Kuhn M.
        Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.
        Endocrinology. 2009; 150: 2382-2387
        • Wada A.
        • Tsutamato T.
        • Maeda Y.
        • Kanamori T.
        • Matsuda Y.
        • Kinoshita M.
        Endogenous atrial natriuretic peptide inhibits endlthelin-1 secretion in dogs with severe congestive heart failure.
        Am J Physiol. 1996; 270: H1819-H1824
        • Karam H.
        • Bruneval P.
        • Clozel J.P.
        • Löffler B.M.
        • Bariéty J.
        • Clozel M.
        Role of endothelin in acute renal failure due to rhabdomyolysis in rats.
        J Pharmacol Exp Ther. 1995; 274: 481-486